Form 4 Filing for Intelligent Bio Solutions Inc.

This filing details transactions made by Harry Simeonidis, Chief Executive Officer of Intelligent Bio Solutions Inc. On March 18, 2026, Simeonidis was granted 9,150 restricted shares of Common Stock under the 2019 Long Term Incentive Plan, subject to time-based vesting. Additionally, on the same date, he was granted 21,350 restricted shares of Common Stock under the same plan, which are subject to both performance-based and time-based vesting. All share amounts presented are on a post-1-for-10 reverse stock split basis, which occurred on December 15, 2025. The awarded shares are subject to forfeiture until vested.